Antibiotic resistance is a global threat for public health. It is widely acknowledged that 10 antibiotics at sub-inhibitory concentrations are important in disseminating antibiotic 11 resistance via horizontal gene transfer. While there is high use of non-antibiotic human-12 targeted pharmaceuticals in our societies, the potential contribution of these on the spread of 13 antibiotic resistance has been overlooked so far. Here, we report that commonly consumed 14 non-antibiotic pharmaceuticals, including nonsteroidal anti-inflammatories (ibuprofen, 15 naproxen, diclofenac), a lipid-lowering drug (gemfibrozil), and a β-blocker (propanolol), at 16 clinically and environmentally relevant concentrations, significantly accelerated the 17 conjugation of plasmid-borne antibiotic resistance genes. We looked at the response to these 18 drugs by the bacteria involved in the gene transfer through various analyses that included 19 monitoring reactive oxygen species (ROS) and cell membrane permeability by flow 20 cytometry, cell arrangement, and whole-genome RNA and protein sequencing. We found the 21 enhanced conjugation correlated well with increased production of ROS and cell membrane 22 permeability. We also detected closer cell-to-cell contact and upregulated conjugal genes. 23
Introduction 33
Increasing levels of antibiotic resistance occurring in bacteria is seen to be a major threat for 34 human health, which is put forward by World Health Organization. Currently, this is causing 35 at least 700 000 deaths worldwide annually 1 . The acquisition of antibiotic resistance can 36 mainly occur through a mutation in bacterial DNA or by obtaining antibiotic resistance genes 37 (ARGs) through horizontal gene transfer (HGT) 2,3 . HGT consists of three different 38 pathways: conjugation, transformation and transduction. Among them, conjugation is a main 39 mechanism for disseminating antibiotic resistance 4 . During conjugation, the exchange of 40 genetic material between the donor and recipient bacteria occurs by direct cell-to-cell contact 41 and by a connecting pilus 5 . Typically, the exchange is mediated by mobile genetic elements, 42 such as a conjugative plasmid. 43 44 It is commonly acknowledged that the emergence and spread of antibiotic resistance is 45 largely due to misuse and overuse of antibiotics in clinical, veterinary, and agricultural 46 settings 6 . Exposure of microorganisms to antibiotics that are below the minimal inhibitory 47 concentration (MIC) can promote HGT 7,8 . For example, antibiotics aminoglycoside and 48 fluoroquinolone were shown to induce genetic transformability in pathogen Streptococcus 49 pneumoniae 7 . Although the consumption of non-antibiotic pharmaceuticals occupy 50 8 up 15-fold at exposure of 50 mg/L propanolol (Fig. 2a ). The fold changes of ROS generation 157 in the recipient was relatively lower than those in the donor, in which the highest change was 158 3-fold at the exposure of 50 mg/L ibuprofen (Fig. 2b) . Moreover, the effects of diclofenac 159 and propanolol on ROS generation in the donor were concentration-dependent (r=0.84, P < 160 0.05 and r=0.86, P < 0.01 for diclofenac and propanolol, respectively), higher ROS levels 161 were detected with increasing concentrations of pharmaceuticals. In contrast the effects of 162 ibuprofen, naproxen and gemfibrozil exhibited a concentration-independent effect on ROS 163 (P > 0.05). It should be noted that the increase of ROS generation was due to the dosage of 164 pharmaceuticals, based on the fact that ethanol did not increase the ROS generation. 165 166 We found that an ROS scavenger (thiourea) could eliminate the over-production of ROS, 167 caused by non-antibiotic pharmaceuticals, in both donor and recipient bacteria (P < 0.05) 168 ( Fig. 2c, 2d, Fig. S1 ). With the exception that 0.5 mg/L of diclofenac and propanolol could 169 still significantly increase ROS generation in both the donor and recipient (P < 0.05, Fig. 2c,  170 2d). In that case there may be some other ROS produced that are not eliminated by thiourea. 171
Nonetheless, we were able to experimentally reverse the effects of ROS on the conjugation 172 process, by adding thiourea during the mating period. As illustrated in Fig. 2e and Fig. S1 , 173 the conjugative transfer frequency declined significantly for all the pharmaceuticals (P < 174 0.05) in the presence of the scavenger. For example, with 0.5 mg/L gemfibrozil and 175 naproxen, the fold change of transfer frequency decreased from 5-fold and 4-fold to only 1.3-176 fold and 1.1-fold, respectively, when the scavenger was added. No significant increase was 177 observed in the transfer frequency between the controls (no drug) and the scavenger-dosed 178 drug groups ( Fig. 2e) , indicating that the ROS are playing an important role in the 179 pharmaceutical enhanced conjugation process. 180 the non-antibiotic pharmaceuticals dosed groups and the control groups (no drugs applied) of 183 the donor and recipient bacteria. This was conducted to further understand the effects of these 184 pharmaceuticals on conjugation. It was seen that the pharmaceuticals enhanced ROS 185 production-related proteins and genes significantly in both donor and recipient (Fig. 2f, Fig.  186 2g, Tables S3-S6 ). For the donor bacterium, these pharmaceuticals enhanced expression of 187 redox-sensing genes, oxyR and soxR, which are the regulators of genes for defending 188 oxidative stress 23, 24 (Fig. 2f ). Proteins responsible for alkyl hydroperoxide reductase (AhpF) 189 and superoxide dismutase (SodC) activities increased significantly with the dosage of 190 pharmaceuticals (q < 0.01). For example, expression of SodC was enhanced 4.7-fold when 191 exposed to 0.5 mg/L propanolol. Correspondingly, genes coding for hydroperoxide reductase 192 (ahpC and ahpF), oxidative demethylase (alkB), superoxide dismutase (sodB and sodC) and 193 superoxide response (soxS) increased under the exposure of pharmaceuticals by 1. 1-to 4.8-194 fold. These genes are involved in the bacterial response to high-level oxidative stress 25 . 195 Noticeably, iopromide of 1.0 mg/L had the least effect on the ROS-related gene expression 196 levels in the donor bacterium, which is in agreement with lower levels of ROS generation 197 detected for that exposure ( Fig. 2a ). For the recipient bacterium, these non-antibiotic 198 pharmaceuticals increased protein abundances of alkyl hydroperoxide reductase (AhpF) and 199 hydroperoxide peroxidase (Tpx), but only ibuprofen and gemfibrozil enhanced the expression 200 of superoxide dismutase protein (SodF) (Fig. 2g ). Additionally, the expression of the redox-201 sensing gene (oxyR) and the superoxide dismutase regulators (sodA and sodB), were 202 significantly enhanced under the exposure of all pharmaceuticals. 203 204
Cell membrane variations link to increased conjugation 205
If the cell membranes become more permeable, it will be easier for plasmid to transfer from 206 donor to recipient bacteria during the conjugative process 26 . We speculate that non-antibiotic 207 pharmaceuticals might increase conjugative transfer by affecting cell membrane. Thus, we 208 tested the cell membrane permeability by flow cytometry in the bacteria in the presence and 209 absence of the pharmaceuticals. For the donor bacteria, naproxen, gemfibrozil, diclofenac, 210 and propanolol at the low concentration of 0.005 mg/L were seen to increase the cell 211 membrane permeability significantly (P < 0.05) ( Fig. 3a and Fig. S2 ). Ibuprofen at 212 concentrations higher than 0.05 mg/L significantly increased the membrane permeability, 213 while iopromide had no effect (Fig. 3a) . The impact of ibuprofen on the donor bacteria's cell 214 membrane permeability was concentration-dependent (r=0.98, P < 0.01), such that the 215 membrane permeability increased with the increase of ibuprofen, and a 2.5-fold change was 216 detected at 50.0 mg/L. In contrast, for the other non-antibiotic pharmaceuticals, the 217 membrane permeability changes were not seen to be concentration-dependent (P > 0.05). The 218 results matched well with the conjugative transfer changes detected, where the frequency was 219 more enhanced with increasing ibuprofen concentrations ( Fig. 1a and 1b ). For the recipient 220 bacteria, all the chosen concentrations of ibuprofen, naproxen, gemfibrozil, diclofenac, and 221 propanolol enhanced the membrane permeability significantly (P < 0.05) (Fig. 3b and Fig. 222 S2) . These increases in cell membrane permeability are likely contributing to the increased 223 conjugation detected for these non-antibiotic pharmaceuticals. 224
225
We examined the effect of the pharmaceuticals on the cell morphology and arrangement 226 during the conjugation periods by transmission electron microscopy (TEM). During exposure 227 to the pharmaceuticals (excepting for iopromide) the cells became more compact and closer 228 (Arrow a in Fig. 3c ), and cell membranes were partially damaged (Arrow b in Fig. 3c ). In 229 contrast, for iopromide, the cells remained separate and intact ( Fig. S3 ). During the 230 conjugation process direct donor and recipient cell contact is a necessity for the plasmid 231 transfer 27 . Thus, the closer cell contact and membrane damage detected here agrees with the 232 changes in membrane permeability and the correspondingly higher levels of gene transfer 233 detected in the presence of the pharmaceuticals. This provides further explanation for the 234 enhanced conjugative transfer detected for ibuprofen, naproxen, gemfibrozil, diclofenac and 235 propranolol, and is in agreement with the lack of effect by iopromide. 236 237 Moreover, the variations of cell membranes induced by non-antibiotic pharmaceuticals were 238 supported by the analyses at both RNA and protein levels. Core genes and proteins related to 239 cell membrane structure and function showed significant changes under the exposure of the 240 non-antibiotic pharmaceuticals (Tables S7-S10 ). Regulator proteins, which alter the levels of 241 outer membrane channels and membrane permeability 28, 29 , increased significantly after 242 exposure to the non-antibiotic pharmaceuticals (q < 0.01). For example, OmpC and OmpF in 243 the donor bacteria, and OmpA, OprH, OprL and OprQ in the recipient bacteria, showed 244 significant enhancement of abundance in all of the five pharmaceutical-dosed groups ( Fig. 3d  245 and 3e). The increase was as high as 2.4-fold. The correspondingly relevant genes also 246 showed significantly increased expression. This included ompC, ompF, ompN, ompR in the 247 donor bacteria, and oprG, oprH, oprI, oprJ in the recipient bacteria. Noticeably, the 248 expression of the genes ompC, ompF, ompN in the donor bacteria were not changed for 249 iopromide, while the other five pharmaceuticals caused up to 2.5-fold change. A decrease in 250 expression of ompQ and ompR genes was detected in the recipient bacteria after dosing 251 iopromide, whereas ibuprofen, naproxen, gemfibrozil, diclofenac and propanolol caused their 252 increased expression from 1.3-1.8 folds. These variations also partially explain the different 253 effects of pharmaceuticals on the conjugation process. In addition, putative genes which code 254 for outer membrane proteins in donor bacteria 30 , also increased significantly due to the 12 effects of non-antibiotic pharmaceuticals. For example, the genes csgG, cusA, pgaA, ybhG, 256 ydcU, yfaZ had increased expression by up to 8 folds (with iopromide exposure had the least 257 increase effect), and these may also be contributing to the increased cell membrane 258 permeability. 259
260
Other key factors regulating conjugative process 261
Genes on the conjugative plasmid are also key factors in regulating conjugation, which 262 involves coordinated processes of replication, partitioning and conjugation 31 . In particular, 263 the global regulator korB alters operon expression of the IncP-α RP4 plasmid. Under the 264 exposure of these non-antibiotic pharmaceuticals the expression of korB was repressed by 265 1.1-to 1.7-fold decrease (Fig. 4a ), thus, leading to the enhanced expression of genes for the 266 mating-pair apparatus, replication and conjugative regulators. For example, ibuprofen at 0.5 267 mg/L caused enhanced expression of the conjugative transfer transcriptional regulator, traG 268 and trbD by up to 2.2-and 1.7-fold, respectively; caused up-regulation of the mating-pair 269 apparatus, including trbA, trbK, trfA2, by up to 235-fold; and it increased expression of the 270 replication regulator, where a 2-fold change in traC1 was detected. Similar changes were 271 seen when the RP4 plasmid was exposed to naproxen, gemfibrozil, diclofenac, and 272 propanolol. Noticeably, iopromide had the least effect on korB expression, with only a 1.1-273 fold decrease, thus, having lower effect on other core genes in RP4 plasmid. For example, 274 expression of trfA2 gene, which is responsible for mating pair formation and replication in 275 the RP4 plasmid 32,33 , showed a 15-fold decrease under the effect of iopromide. However, the 276 expression of the gene was enhanced by 56 to 271 folds when exposed to the other five 277 pharmaceuticals (Table S11 ). As for the other factors influencing the transfer frequency, this 278 also partially explains why iopromide was less effective in promoting conjugal process. 279 pilin-related genes in RP4 plasmid include traB, traE, traF, and traP 34 . Under the exposure 282 of ibuprofen, naproxen, gemfibrozil and diclofenac, all these four genes were up-regulated by 283 1.1-to 15-fold enhancement compared to the control group. For propanolol, increased 284 expression of traF and traP to 2-fold was detected, but decreased expression levels of traB 285 and traE to 1.2-fold occurred. Significant increases of pilin gene expression were not 286 detected for iopromide exposure, although we observed decreased expression of traB, traE 287 and traF. 288
289
Another contributing factor to conjugation is the direct cell-to-cell contact 27 , to which 290 fimbriae are important for bacterial cell adhesion. Fimbriae generation and functions are 291 regulated within the regulator operons fim, pil, yad, ybg, ycb, yfc, yra, ycg 35-37 . In this study, 292 genes and proteins related to fimbriae adhesion were up-regulated significantly under the 293 exposure of the five non-antibiotic pharmaceuticals, excluding the effect of iopromide 294 (Tables S12-S14). For example, in the donor bacteria the gene expression was enhanced by 295 as high as 17.8-fold under the effect of 0.5 mg/L gemfibrozil ( Fig. 4b ). While in the recipient 296 bacteria, the highest increase was to 0.5 mg/L naproxen, with a 4.3-fold increase (Fig. 4c ). In 297 comparison, iopromide exposure repressed expression of most of the fimbriae-related genes 298 in the donor bacteria by 1.2 to 1.8 folds. 299 300
Antibiotic-like features caused by non-antibiotic pharmaceuticals 301
Antibiotics at sub-inhibitory concentrations are known to promote horizontal dissemination 302 of antibiotic resistance, which is associated with the SOS response of bacteria 6, 8 . In this 303 study, we found the non-antibiotic pharmaceuticals also had significant effects on SOS 304 response in both donor and recipient bacteria ( Fig. 5 , Tables S15-S18). Altered gene yeb in the donor, and sox in the recipient, with a total of seven genes being affected 38 . Under 307 the exposure of ibuprofen, naproxen, and propanolol, all of these core genes responsible for 308 SOS response had increased expression by 1.1 to 4.2 folds. While gemfibrozil and diclofenac 309 caused enhanced expression of six of the seven genes, with the largest change being 5.4-fold. 310
In contrast, iopromide caused increased expression of three of the seven genes, which were 311 umuD in the donor (1.1-fold), and soxD (1.5-fold) and soxR in the recipient (4.0-fold); and 312 caused decreased expression of the other four genes by 1.1-to 1.5-fold. Thus, the SOS 313 response could also contribute to the non-antibiotic pharmaceutical-enhanced conjugation, 314 and help explain the differences detected under the exposure of different pharmaceuticals. 315
316
In addition to the SOS response, these non-antibiotic pharmaceuticals also had influence on 317 other effects that antibiotics may cause on both the donor and recipient, this included the 318 enhanced expression of efflux pumps, increased levels of universal stress, and even elevated 319 levels of repressor genes which regulate antibiotic-sensitivity. Core operons of these effects 320 are mdt, usp, kdg in donor, and czc, ttg in the recipient bacteria 39, 40 . Despite some 321 fluctuations, these five non-antibiotic pharmaceuticals caused increased expression of the 322 relevant genes; while exposure to 1.0 mg/L iopromide showed the least effects on changed 323 gene expression (Tables S19-S20). 324 325 Discussion 326
Pharmaceuticals are being consumed at alarmingly increased levels in recent years. The 327 global pharmaceuticals market was worth $935 billion in 2017, and will reach $1170 billion 328 in 2021, with a 5.8% yearly growth 9,10 . Among the highly-consumed pharmaceuticals, 329 antibiotic consumption is only $43 billion, which occupies a 4.6% portion of the market. The 15 dominant portion of the market is non-antibiotic pharmaceuticals 9,10 . It is well studied that 331 antibiotics at sub-inhibitory concentrations can facilitate the spread of antibiotic resistance 41-332 45 . However, the contribution of non-antibiotic human-targeted pharmaceuticals on the spread 333 of antibiotic resistance have been severely overlooked. In this study, we demonstrated that 334 the exposure of bacteria to five commonly consumed non-antibiotic human-targeted 335 pharmaceuticals (ibuprofen, naproxen, gemfibrozil, diclofenac, and propanolol) caused 336 increased dissemination of antibiotic resistance via conjugative transfer. In contrast, the 337 diagnostic drug, iopromide, did not result in increased gene transfer. The changes of absolute 338 number of transconjugants and the transfer frequency both increased significantly under the 339 exposure of ibuprofen, naproxen, gemfibrozil with the concentrations as low as 0.005 mg/L, 340 or in the presence of diclofenac, propanolol with concentrations higher than 0.05 mg/L. 341
Noticeably, we further confirmed successful transfer of the RP4 plasmid by PCR of plasmid 342 genes, testing the antibiotic MIC of the transconjugants, and conducting reverse transfer from 343 the transconjugants. These findings enabled ruling out any co-selective effects or 344 mutagenesis, and coincided with the phenotypic results. Compared with the conjugation 345 effects caused by sub-inhibitory antibiotics, the fold changes were comparable, or lower, for 346 example, sub-inhibitory tetracycline in drinking water resulted in a 10-fold increasement for 347 the transfer of the conjugative element from Enterococcus faecalis to Listeria monocytogenes 348 46 . However, considering the consumption is relatively high, the effects caused by non-349 antibiotic pharmaceuticals cannot be ignored. Moreover, this is the first time to report that 350 these five commonly consumed non-antibiotic pharmaceuticals (ibuprofen, naproxen, 351 gemfibrozil, diclofenac, and propanolol) can enhance the spread of antibiotic resistance under 352 both clinical-and environmentally-relevant concentrations. 353 gene transfer by culturing-and fluorescence-based methods 21,47 , as well as by advanced 356 molecular techniques (Fig. 6 ). The higher levels of ROS triggered by these non-antibiotic 357 pharmaceuticals is likely a major influence on the increased gene transfer. Under the 358 exposure of ibuprofen, naproxen, gemfibrozil, diclofenac, and propanolol, intracellular ROS 359 production was increased significantly (P < 0.05). Both RNA and protein levels indicated 360 significant increased expression of oxidative regulators, oxyR and soxR, and this coincided 361 with the over-expression of antioxidant genes, including superoxide dismutase sod and 362 hydroperoxide reductase ahp (P < 0.05) 23, 24 . After adding the ROS scavenger, these non-363 antibiotic pharmaceuticals did not cause enhanced intracellular ROS generation for both the 364 donor and recipient. Consequently, the enhanced conjugative transfer frequency was 365 eliminated by addition of the ROS scavenger. In addition, iopromide did not promote the 366 conjugative transfer, likely because it did not cause ROS stress in the donor and recipient 367 cells. 368
369
We also found that the condition of the cell membrane is an important factor for facilitating 370 conjugation by detecting changes in cell membrane permeability and observing cell-to-cell 371 contact. Elevated cell membrane permeability was detected in both the donor and recipient 372 cells under the exposure of ibuprofen, naproxen, gemfibrozil, diclofenac, and propanolol. On 373 the contrary, iopromide did not cause similar effects. Transcriptional and protein expression 374 levels also supported these findings. These exposures caused increased levels of outer 375 membrane regulon proteins Omp and Opr, together with the corresponding up-regulated omp 376 and opr genes, while iopromide exposure caused lower levels of change. The outer 377 membrane of Gram-negative bacteria is considered to be a semi-permeable barrier, where 378 increased permeability could enable increased entry of plasmids 48 . It is also reported that the 379 transient membrane permeability has evolutionary implications and can facilitate horizontal 380 gene transfer 49 . Additionally, direct cell-to-cell contact is required for transfer of plasmids 381 from donor to recipient via pilin bridge 27 . In this study, TEM indicated that ibuprofen, 382 naproxen, gemfibrozil, diclofenac, and propanolol could promote cell contact, while 383 iopromide did not. We also found that the enhanced levels of fimbriae-related proteins and 384 genes may play a role. Fimbriae is reported to increase cell adhesion and promote the 385 formation of biofilms 50 . In this study, iopromide had the least effect on fimbriae-386 gene/protein regulations compared to the other five pharmaceuticals. Therefore, the 387 variations of cell membrane integrity, permeability and cell-to-cell contact is likely 388 contributing to the enhanced conjugation ( Fig. 6) . 389 390 For the RP4 plasmid important plasmid borne factors for the conjugative process are the 391 DNA-transfer replication (Dtr) and the mating pair formation (Mpf) systems 51 . The Dtr 392 system is essential for plasmid replication and the Mpf system is responsible for the 393 generation of pilin 52 . Upon exposure to the non-antibiotic pharmaceuticals significant 394 variations of both the Dtr and Mpf systems were detected. For Dtr, the traC gene was up-395 regulated in the presence of non-antibiotic pharmaceuticals. For the Mpf system, the genes 396 trbK, trfA (mating-pair apparatus), and traF, traP (pilin regulator), had increased levels of 397 expression under the exposure of ibuprofen, naproxen, gemfibrozil, diclofenac, and 398 propanolol; while decreased levels were observed when exposing to iopromide. Thus, we 399 propose that variation of the RP4 plasmid gene expression, caused by the pharmaceutical 400 exposure, is contributing to the enhanced conjugative transfer (Fig. 6) . 401 402 Interestingly, we also found these non-antibiotic pharmaceuticals caused antibiotic-like 403 bacterial responses. Here we detected the increased expression of genes and proteins involved 18 in the SOS response (lexA, umuC, umuD and soxR) , universal stress (Usp), efflux pump 405 (aaeX, mdtJ, yhiI and czcA), and antibiotic-sensitivity (KdgR). Other in vivo studies show 406 that some pharmaceuticals can cause stress on cells. For example in humans, ibuprofen could 407 enhance oxidative stress in plasma during extreme exercise 53 and induce prolonged stress in 408 a rat model 54 . Naproxen can induce oxidative stress and genotoxicity in male Wistar rats 55 . 409 Diclofenac is also demonstrated to possess a broad antimicrobial activity in vitro 56 . It is also 410 reported that human-targeted non-antibiotic drugs boost antibiotic-like side effects on the gut 411 microbiome 11 . Here they detected that bacterial mutant strains lacking TolC, which is 412 responsible for efflux of antibiotics, became more sensitive to antibiotics and human-targeted 413 non-antibiotic drugs. 414
415
We aimed to determine some key features of these non-antibiotic pharmaceuticals 416 contributing to the stimulatory effects on the conjugative process. Our results indicate that 417 non-antibiotic pharmaceuticals that cause increased intracellular ROS generation will likely 418 cause increased gene transfer by conjugation. In addition to these five non-antibiotic 419 pharmaceuticals reported in this study, we previously also reported that carbamazepine could 420 facilitate the conjugative transfer due to enhanced ROS production 20 . Previous studies also 421 documented that these non-antibiotic pharmaceuticals cause negative effects on the health 422 status in animals and humans due to oxidative stress. For example, NSAID-pharmaceuticals 423 (e.g., ibuprofen, naproxen, and diclofenac) have been reported to induce cardiotoxicity by a 424 ROS-dependent mechanism, and were further verified with the addition of antioxidants 57-59 . 425 Therefore, these studies on animals or humans support the increase in ROS in the presence of 426 these non-antibiotic pharmaceuticals. In addition to these non-antibiotic pharmaceuticals, 427
biocides (e.g., triclosan) and heavy metals were also demonstrated to increase ROS 428 generation levels, impose stress-response on bacteria, thus enhancing the uptake potential of 429 conjugal plasmids [60] [61] [62] . Further studies are required to confirm if other non-antibiotic 430 pharmaceuticals follow this pattern of enhancing intracellular ROS generation and potentially 431 contributing to increased bacterial gene transfer. Possibly, a ROS measurement in bacteria 432
could be used to screen for non-antibiotic pharmaceuticals that contribute to spreading 433 antibiotic resistance. 434
435
We looked for chemical structures and properties of these non-antibiotic pharmaceuticals that 436 might be in common in various antibiotics. Four of the pharmaceuticals, ibuprofen, naproxen, 437 gemfibrozil, and diclofenac, harbour benzene rings and carboxyl functional groups. This is 438 similar to antibiotics such as ampicillin, cefalexin and ciprofloxacin (Fig. S4) Both donor and recipient at the concentration of 10 8 cfu/mL were mixed well at a ratio of 1:1 472 to establish the PBS-based conjugative mating system (pH=7.2), with a total volume of 1 mL 473 for each mating system. Different levels of non-antibiotic pharmaceuticals were added to the 474 mating system. This included clinical and environmental relevant concentrations, and sub-475 MIC levels. These were 0.005, 0.05, 0.5, 5, 50 mg/L for ibuprofen, naproxen, gemfibrozil, 476 diclofenac, propanolol, and 0.0001, 0.001, 0.01, 0.1, 1, 5 mg/L for iopromide (due to the 477 solubility). After 8 h-incubation at 25 o C without shaking, 50 µL of the mixture was spread 478 on to LB agar selection plates containing antibiotics to count the number of transconjugants, 21 details are described in Text S3. In addition to the above matings, further sets of conjugative 480 mating systems were established with the addition of 100 µM ROS scavenger, thiourea. The 481 conjugative transfer frequency was calculated from the number of transconjugant colonies 482 divided by the number of recipients. As no nutrient was provided during the mating process, 483 the growths of donor, recipient, and transconjugant were neglected. 484
485
To test for the reverse transfer process, transconjugants obtained from transfer experiment 486 were applied as the new donor, while a mutant strain of E. coli MG1655 with 487 chloramphenicol resistance was the recipient 21 . The conjugation experiments were conducted 488 with the different non-antibiotic pharmaceuticals as described above. The number of 489 transconjugants were counted on Difco TM m Endo Agar plates (to distinguish E. coli and P. 490 putida) with the appropriate antibiotics as described in Text S3. 491 492
Plasmid verification 493
Transconjugants growing on the selective plates were randomly picked, cultured, and stored 494 with 25% glycerol in -80 o C. The plasmids of transconjugants were extracted using the 495 Invitrogen TM PureLink ® Quick Plasmid Miniprep Kit (Life Technologies, USA). The specific 496 traF gene of RP4 plasmid was amplified by PCR, and the amplicons were observed using 1% 497 agarose gel electrophoresis. To further verify the identity of the plasmid, PCR was applied 498 for detection of the tetA and bla genes, which are harboured on the RP4 plasmid. PCR 499 primers and conditions are described in Text S4 and Table S21 . 500 501 Transmission electron microscopy 502 experiments were performed as described above and TEM samples were collected after 8-h's 504 mating with either 0.5 mg/L ibuprofen, naproxen, gemfibrozil, diclofenac, propanolol, or 0.1 505 mg/L iopromide. Sample preparations were performed according to standard procedures as 506 previously described 69 , and details are illustrated in Text S5. A JEOL JEM-1011 (JEOL, 507 Japan) operated at 80 kV was applied to obtain the images. 508
509

ROS generation and cell membrane permeability detection 510
ROS generation and cell membrane permeability were detected based on the fluorescence-511 method as described in Text S6. In brief, 20 µM of DCFDA and 2 mM of propidium iodide 512 (PI) were applied to dye the donor and recipient cells after exposure to the various non-513 antibiotic pharmaceuticals. The dyed cells were then detected by a CytoFLEX S flow 514 cytometer (Beckman Coulter, USA). The DCFDA-and PI-stained cells were recorded, and 515 calculated as fold changes comparing to the control group (absence of added 516 pharmaceuticals). 517 518
Whole-genome RNA sequence analysis and bioinformatics 519
In order to analyze the gene expression levels during the conjugative process, the same 520 conjugation experiments were performed as described above and RNA was extracted after 2-521 h's mating with either 0.5 mg/L ibuprofen, naproxen, gemfibrozil, diclofenac, propanolol, or 522 0.1 mg/L iopromide. As bacterial mRNA expressions respond quickly to external stress, 2-h's 523 mating time was chosen as done previously 47, 60 . Total RNA (containing the mixture of donor 524 and recipient bacteria) was extracted using RNeasy Mini Kit (QIAGEN ® , Germany) with an 525 extra bead-beating step for the cell lysis process 20 . The RNA samples with biological 526 triplicates were then submitted to Macrogen Co. (Seoul, Korea) for strand specific cDNA 527 23 library construction and Illumina paired-end sequencing (HiSeq 2500, Illumina Inc., San 528 Diego, CA). Raw data were analyzed using the bioinformatic pipeline described previously 529 69 . Noticeably, the database used for alignment was the combination of reference genome of 530 E. coli K-12 (NC_000913), P. putida KT2440 (NC_002947), and IncPα RP4 plasmid 531 (L27758), which were obtained from National Center for Biotechnology Information (NCBI). 532
Regarding the bioinformatic pipeline, NGS QC Toolkit (v2.3.3), SeqAlto (version 0.5), and 533
Cufflinks (version 2.2.1) were applied to treat the raw sequence reads and to analyze the 534 differential expression for triplicated samples. CummeRbund package in R was used to 535 conduct the statistical analyses. We used the measure of "fragments per kilobase of a gene 536 per million mapped reads" (FPKM) to quantify gene expression. The differences of gene 537 expression between the control (no added pharmaceuticals) and the pharmaceutical-exposed 538 groups were presented as log2 fold-changes (LFC). 539 540
Proteomic analysis and bioinformatics 541
Conjugation experiments were established as described above to compare proteins expressed 542 in the donor and recipient bacteria during the absence and presence of the non-antibiotic 543 pharmaceuticals. Initially, the optimal length of exposure period was examined in the 544 conjugations when exposed to either 0.5 mg/L gemfibrozil or propranolol. Total proteins 545 from the mixture of donor and recipient bacteria were extracted after 2, 4, 6, and 8 h mating 546 as described previously 20 . For peptide preparations, the extracted proteins were treated by 547 reduction, alkylation, trypsin digestion, and ziptip clean-up procedures as described 548 previously 70 . The peptide preparations were then loaded to mass spectrometer. Qualitative 549 protein libraries were constructed by information dependent analysis; while quantitative 550 protein determination was based on SWATH-MS 70 using biological triplicate samples. 551
Database and software analyses and settings were performed as described in Text S7. A 552 stringency cut-off of false discovery rate (q value) less than 0.01 was used to identify the 553 proteins with significant different expression levels. Based on the number of proteins 554 showing significant variations, 8 h was determined as the best exposure time for the 555 proteomic analysis. Thus, another set of conjugation experiment was established as described 556 above using the 8 h mating period in the presence of either ibuprofen, naproxen, gemfibrozil, 557 diclofenac, or propranolol, each at 0.5 mg/L, or with iopromide at 0.1 mg/L. Following that, 558 for each of the conjugation experiments, the proteins were extracted, peptide preparations 559 prepared and proteomic analyses were performed as described above. 560 561
Correlation tests 562
Correlation tests were conducted to identify whether the phenotypic data (including 563 conjugative transfer frequency, ROS generation and cell membrane permeability) were 564 concentration-dependent. Pearson correlation formula (Eq. 1) was applied to calculate the 565 correlation coefficient value r, followed by consulting the correlation coefficient table. Fold changes of expression of core genes and proteins related to ROS production in donor 808 bacteria. (g) Fold changes of expression of core genes and proteins related to ROS production 809 in recipient bacteria. Significant differences between non-antibiotic-dosed samples and the 810 control were analyzed by independent-sample t test, * P < 0.05, ** P < 0.01, and *** P < 0.001. 811
For (c)-(g), figures shown are 0.5 mg/L for ibuprofen, naproxen, gemfibrozil, diclofenac, 812 propanolol, and 1.0 mg/L for iopromide. 813 
